A nationwide survey indicates that there are significant differences between the public's view of pharmaceutical companies and the industry's perception of itself. These differences have caused the pharmaceutical industry to lose the trust of many.
The survey asked questions of consumers, physicians, health insurers, researchers and policymakers. The survey found that:
- More than 60 percent of industry stakeholders believe drug companies manipulate or suppress negative clinical trials to maximize sales.
- Almost all the consumers surveyed (94 percent) and most stakeholders (81 percent) feel drug companies promote their products far too aggressively when it comes to unapproved uses.
- Consumers are split roughly evenly between believing that pharmaceutical companies consider important unmet medical needs when deciding to develop a new drug (55 percent) versus believing that they tend to develop "me-too" and "lifestyle" drugs with the greatest sales potential (45 percent).
Good news! More people are escaping out of the illusion and deception of the drug companies and starting to clearly see the truth.
This new PricewaterhouseCoopers report, citing a declining trust in the reputation of the mega-pharmaceuticals, is yet another indication that my vision to reconfigure and reform the deadly state of conventional health care in America is a bit closer to becoming a reality.
Only the reputation of the oil industry fell more steeply in the eyes of the public.
The main reason is that the public is absolutely right in their estimation that drug companies manipulate or suppress negative clinical trials, promote their toxic products for unapproved uses, and focus on developing drugs that are either not any better than older ones or "lifestyle" concoctions with better sales potential.
Keep up the good work, folks. But, please be aware, the battle is merely beginning ...
On Vital Votes, reader Jeff from Stamford, Connecticut says: